MicroInvasive Glaucoma Surgery (MIGS) In Daily Practice

Iqbal Ike K. Ahmed, MD, FRCSC, opens up discussion on preferred minimally invasive glaucoma surgery (MIGS) procedures. Mark J. Gallardo, MD; I. Paul Singh, MD; Mahmoud A. Khaimi, MD; David Richardson, MD; and Nathan M. Radcliffe, MD, each describe their approach to MIGS and discuss the mechanism of action of ABiC iTrack (Ellex).

Misconceptions About Selective Laser Trabeculoplasty (SLT)

Iqbal Ike K. Ahmed, MD, FRCSC, Nathan M. Radcliffe, MD; I. Paul Singh, MD; Mahmoud A. Khaimi, MD; Mark J. Gallardo, MD; and David Richardson, MD, discuss the the misconceptions surrounding selective laser trabeculoplasty (SLT), safety and efficacy of SLT and highlight the advantages of minimizing the medication burden for patients.

Interventional Glaucoma: SLT AND MIGS

At ASCRS 2018 in Washington, DC, a group of surgeons experienced in interventional glaucoma therapies sat down to discuss the roles of selective laser trabeculoplasty (SLT) and microinvasive glaucoma surgery (MIGS) for treatment of open angle glaucoma (OAG).

How Does Canaloplasty Compare to Other Glaucoma Treatments?

How does Canaloplasty compare to other glaucoma treatments in terms of IOP Lowering benefits and average medication?  Here’s a summary from Dr. Douglas J. Rhee’s talk given on April 13, 2018 during the ASCRS 2018 Glaucoma Day “Is Trabeculectomy...

Ab-Interno Canaloplasty: Two-Year Results

[Photo Credit: www.augencentrumkoeln.de] Not everyone with glaucoma is excited about having an implant (however small) permanently placed in the eye. Additionally, not everyone with glaucoma has a cataract. Unfortunately, all current FDA approved minimally invasive...

Hydrus™ Microstent 2-Year Results

08.16.2018 NEWS UPDATE: Hydrus microstent wins FDA approval. The FDA has approved the use of the Hydrus microstent in conjunction with cataract surgery to reduce IOP in patients with mild to moderate primary open-angle glaucoma. Source: https://bit.ly/2MX19sM There...

EyeOP1® Ultrasound Cyclo-Plasty (UCP) Glaucoma Treatment

EyeOP1® Ultrasound Cyclo-Plasty (UCP) In late October it was announced that the Chinese FDA (but not yet the American FDA) had approved a new non-invasive glaucoma treatment called EyeOP1® Ultrasound Cyclo-Plasty (also known as Ultrasound Ciliary-Plasty, or UCP)....

VYZULTA™: A New FDA Approved Glaucoma Medication with Dual Action

On November 2, 2017, the FDA approved VYZULTA™ (latanoprostene bunod 0.024%) for the treatment of glaucoma. This newly available medication treats glaucoma in two distinct ways. One of these methods of protecting the optic nerve has already been available to those...

Pin It on Pinterest